Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s480. https://doi.org/10.25251/skin.8.supp.480